Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1977 2
1978 2
1979 6
1980 8
1981 5
1982 3
1983 8
1984 7
1985 6
1986 14
1987 12
1988 11
1989 10
1990 9
1991 7
1992 15
1993 9
1994 9
1995 17
1996 9
1997 9
1998 14
1999 14
2000 9
2001 16
2002 11
2003 16
2004 8
2005 12
2006 10
2007 10
2008 15
2009 10
2010 10
2011 8
2012 11
2013 13
2014 12
2015 6
2016 10
2017 4
2018 12
2019 2
2020 3
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

401 results

Results by year

Filters applied: . Clear all
Page 1
Salbutamol and ipratropium by inhaler is superior to nebulizer in children with severe acute asthma exacerbation: Randomized clinical trial.
Iramain R, Castro-Rodriguez JA, Jara A, Cardozo L, Bogado N, Morinigo R, De Jesús R. Iramain R, et al. Pediatr Pulmonol. 2019 Apr;54(4):372-377. doi: 10.1002/ppul.24244. Epub 2019 Jan 22. Pediatr Pulmonol. 2019. PMID: 30672140 Clinical Trial.
OBJECTIVE: To compare the efficacy of salbutamol and ipratropium bromide by MDI versus by NEB in severe asthma exacerbations. ...CONCLUSION: Even in severe asthma exacerbations administration of salbutamol and ipratropium by MDI with valved-holding cha …
OBJECTIVE: To compare the efficacy of salbutamol and ipratropium bromide by MDI versus by NEB in severe asthma exacerbations. …
Association Between Intravenous Magnesium Therapy in the Emergency Department and Subsequent Hospitalization Among Pediatric Patients With Refractory Acute Asthma: Secondary Analysis of a Randomized Clinical Trial.
Schuh S, Freedman SB, Zemek R, Plint AC, Johnson DW, Ducharme F, Gravel J, Thompson G, Curtis S, Stephens D, Coates AL, Black KJ, Beer D, Sweeney J, Rumantir M, Finkelstein Y; Pediatric Emergency Research Canada. Schuh S, et al. JAMA Netw Open. 2021 Jul 1;4(7):e2117542. doi: 10.1001/jamanetworkopen.2021.17542. JAMA Netw Open. 2021. PMID: 34279646 Free PMC article. Clinical Trial.
In the randomized clinical trial, 816 otherwise healthy children aged 2 to 17 years with Pediatric Respiratory Assessment Measure (PRAM) scores of 5 points or higher after initial therapy with systemic corticosteroids and inhaled albuterol with ipratropium bromide w …
In the randomized clinical trial, 816 otherwise healthy children aged 2 to 17 years with Pediatric Respiratory Assessment Measure (PRAM) sco …
Effect of Nebulized Magnesium vs Placebo Added to Albuterol on Hospitalization Among Children With Refractory Acute Asthma Treated in the Emergency Department: A Randomized Clinical Trial.
Schuh S, Sweeney J, Rumantir M, Coates AL, Willan AR, Stephens D, Atenafu EG, Finkelstein Y, Thompson G, Zemek R, Plint AC, Gravel J, Ducharme FM, Johnson DW, Black K, Curtis S, Beer D, Klassen TP, Nicksy D, Freedman SB; Pediatric Emergency Research Canada (PERC) Network. Schuh S, et al. JAMA. 2020 Nov 24;324(20):2038-2047. doi: 10.1001/jama.2020.19839. JAMA. 2020. PMID: 33231663 Free PMC article. Clinical Trial.
INTERVENTIONS: Participants were randomized to 3 nebulized albuterol treatments with either magnesium sulfate (n = 410) or 5.5% saline placebo (n = 408). ...CONCLUSIONS AND RELEVANCE: Among children with refractory acute asthma in the emergency department, nebulized magnes …
INTERVENTIONS: Participants were randomized to 3 nebulized albuterol treatments with either magnesium sulfate (n = 410) or 5.5% salin …
[Bronchodilators].
Advenier C, Cerrina J, Duroux P. Advenier C, et al. Sem Hop. 1984 Jan 26;60(3):179-93. Sem Hop. 1984. PMID: 6320443 Review. French.
Bronchodilating drugs can be divided into three main groups: beta-adrenergic stimulants including specific beta-2 receptor agonists (salbutamol, terbutaline, fenoterol) which are the agents of this group used in everyday practice, theophylline and its derivatives, and atro …
Bronchodilating drugs can be divided into three main groups: beta-adrenergic stimulants including specific beta-2 receptor agonists (salb
Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.
Donohue JF, Wise R, Busse WW, Garfinkel S, Zubek VB, Ghafouri M, Manuel RC, Schlenker-Herceg R, Bleecker ER. Donohue JF, et al. BMC Pulm Med. 2016 Apr 30;16(1):65. doi: 10.1186/s12890-016-0223-3. BMC Pulm Med. 2016. PMID: 27130202 Free PMC article. Clinical Trial.
Thus, determining the most effective relief regimen is important in the management of more severe asthma. This study's objective was to evaluate whether ipratropium bromide/albuterol metered-dose inhaler (CVT-MDI) provides more effective acute relief of bronchospasm …
Thus, determining the most effective relief regimen is important in the management of more severe asthma. This study's objective was to eval …
Efficacy of salbutamol and ipratropium bromide in the management of acute bronchiolitis--a clinical trial.
Karadag B, Ceran O, Guven G, Dursun E, Ipek IO, Karakoc F, Ersu RH, Bozaykut A, Inan S, Dagli E. Karadag B, et al. Respiration. 2008;76(3):283-7. doi: 10.1159/000111817. Epub 2007 Nov 28. Respiration. 2008. PMID: 18042975 Clinical Trial.
BACKGROUND: A wide range of drugs are commonly used to treat bronchiolitis, but evidence of their effectiveness is limited. OBJECTIVES: To investigate the efficacy of ipratropium bromide and salbutamol in the treatment of patients with moderate-severe bronchiolitis. …
BACKGROUND: A wide range of drugs are commonly used to treat bronchiolitis, but evidence of their effectiveness is limited. OBJECTIVES: To i …
Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation.
Goggin N, Macarthur C, Parkin PC. Goggin N, et al. Arch Pediatr Adolesc Med. 2001 Dec;155(12):1329-34. doi: 10.1001/archpedi.155.12.1329. Arch Pediatr Adolesc Med. 2001. PMID: 11732951 Clinical Trial.
OBJECTIVE: To determine whether the addition of inhaled ipratropium bromide to inhaled albuterol and systemic corticosteroid therapy was more efficacious than inhaled albuterol and systemic corticosteroids alone in the inpatient treatment of acute asthma exac …
OBJECTIVE: To determine whether the addition of inhaled ipratropium bromide to inhaled albuterol and systemic corticosteroid t …
Randomized pilot trial of ipratropium versus placebo in children with critical asthma.
Murphy K, Mahmood N, Craven D, Gallagher J, Ross K, Speicher R, Rotta AT, Shein SL. Murphy K, et al. Pediatr Pulmonol. 2020 Dec;55(12):3287-3292. doi: 10.1002/ppul.25115. Epub 2020 Oct 21. Pediatr Pulmonol. 2020. PMID: 33049119 Clinical Trial.
INTERVENTIONS: Subjects were randomized to receive either nebulized ipratropium bromide (500 g in 0.9% saline per dose) or an equivalent volume of nebulized 0.9% saline every 6 h until the patient was successfully weaned to albuterol doses every 2 h ("q2 albutero
INTERVENTIONS: Subjects were randomized to receive either nebulized ipratropium bromide (500 g in 0.9% saline per dose) or an equival …
Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.
Zuwallack R, De Salvo MC, Kaelin T, Bateman ED, Park CS, Abrahams R, Fakih F, Sachs P, Pudi K, Zhao Y, Wood CC; Combivent Respimat Inhaler Study Group. Zuwallack R, et al. Respir Med. 2010 Aug;104(8):1179-88. doi: 10.1016/j.rmed.2010.01.017. Epub 2010 Feb 20. Respir Med. 2010. PMID: 20172704 Free article. Clinical Trial.
This was a multinational, randomized, double-blind, double-dummy, 12-week, parallel-group, active-controlled study. Patients with moderate to severe COPD were randomized to ipratropium bromide/albuterol (20/100mcg) Respimat inhaler, ipratropium bromide/alb
This was a multinational, randomized, double-blind, double-dummy, 12-week, parallel-group, active-controlled study. Patients with moderate t …
A Controlled Trial of Inhaled Bronchodilators in Familial Dysautonomia.
Bar-Aluma BE, Efrati O, Kaufmann H, Palma JA, Norcliffe-Kaufmann L. Bar-Aluma BE, et al. Lung. 2018 Feb;196(1):93-101. doi: 10.1007/s00408-017-0073-7. Epub 2017 Dec 12. Lung. 2018. PMID: 29234869 Clinical Trial.
METHODS: We conducted a double-blind, placebo-controlled, randomized clinical trial comparing the beta 2 agonist albuterol with the muscarinic blocker ipratropium bromide in patients homozygous for the IKBKAP founder mutation. Albuterol, ipratropium br …
METHODS: We conducted a double-blind, placebo-controlled, randomized clinical trial comparing the beta 2 agonist albuterol with the m …
401 results